Literature DB >> 7964698

Cognitive disturbances in progressive supranuclear palsy.

I Litvan1.   

Abstract

The cognitive disturbances in progressive supranuclear palsy (PSP) gave rise to the term "subcortical dementia." PSP patients demonstrate prominent recall deficits and moderate forgetfulness although their short-term and implicit perceptual memory processes are intact. PSP patients have both slowed motor responses and dramatically slowed information processing speed. Executive dysfunction appears early in the course of the disease and is relatively severe. The combination of severely slowed information processing and marked executive dysfunction are characteristic of PSP and differentiates it from other dementias. In their landmark description of progressive supranuclear palsy (PSP) as a clinicopathological entity, Steele et al. (1964) reported that cognitive disturbances were present in seven out of their nine patients. Ten years later, Albert et al. (1974) characterized these changes to be part of a "subcortical dementia," They analyzed 5 of their own PSP cases and also reviewed the published literature; they found a common cluster of symptoms, including the presence of forgetfulness, slowness of thought process, emotional or personality changes, and impaired ability to manipulate acquired knowledge. Albert et al. analysis was qualitative, but in the authors' view, clearly differentiated PSP patients from patients with "cortical dementia" who presented with aphasia, apraxia, and/or agnosia. They also suggested that the symptoms found in PSP were similar to those that had previously been described in patients with frontal lobe lesions.

Entities:  

Mesh:

Year:  1994        PMID: 7964698     DOI: 10.1007/978-3-7091-6641-3_6

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  8 in total

1.  The relationship between clinical and pathological variables in Richardson's syndrome.

Authors:  Emma C Schofield; John R Hodges; Thomas H Bak; John H Xuereb; Glenda M Halliday
Journal:  J Neurol       Date:  2011-08-12       Impact factor: 4.849

2.  Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.

Authors:  Kevin Duff; Christopher Randolph; Adam L Boxer
Journal:  Clin Neuropsychol       Date:  2019-09-27       Impact factor: 3.535

3.  Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Kevin Duff; Dana McDermott; Dan Luong; Christopher Randolph; Adam L Boxer
Journal:  J Clin Exp Neuropsychol       Date:  2019-02-04       Impact factor: 2.475

4.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

5.  Brain alterations and mini-mental state examination in patients with progressive supranuclear palsy: voxel-based investigations using f-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging.

Authors:  Ryuichi Takahashi; Kazunari Ishii; Tatsuya Kakigi; Kazumasa Yokoyama; Etsuro Mori; Takamichi Murakami
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-11-09

Review 6.  Targeting tau: Clinical trials and novel therapeutic approaches.

Authors:  Lawren VandeVrede; Adam L Boxer; Manuela Polydoro
Journal:  Neurosci Lett       Date:  2020-05-04       Impact factor: 3.197

7.  Time Distortion in Parkinsonism.

Authors:  Yasuo Terao; Motoyasu Honma; Yuki Asahara; Shin-Ichi Tokushige; Toshiaki Furubayashi; Tai Miyazaki; Satomi Inomata-Terada; Ayumi Uchibori; Shinji Miyagawa; Yaeko Ichikawa; Atsuro Chiba; Yoshikazu Ugawa; Masahiko Suzuki
Journal:  Front Neurosci       Date:  2021-03-19       Impact factor: 4.677

Review 8.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.